Dr. Daniel Brenner, Founder and medical Director at Cambridge Biotherapies, takes us further into ketamine assisted psychotherapy (KAP) and how this works adjunctively for patients struggling with eating disorders and concomitant depression, anxiety, and trauma. Dan has been at the forefront of this treatment, and others such as MDMA and psilocybin – both soon to be available in Massachusetts – as they continue to change the course of treatment for so many.
Podcast: Play in new window | Download